Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
150,648,996
-
Share change
-
+7,749,626
-
Total reported value
-
$1,508,361,145
-
Put/Call ratio
-
0%
-
Price per share
-
$10.01
-
Number of holders
-
244
-
Value change
-
+$80,964,118
-
Number of buys
-
131
-
Number of sells
-
103
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2025
As of 30 Sep 2025 Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) had 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 150,648,996 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., Rubric Capital Management LP, TPG GP A, LLC, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, Nantahala Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and NEUBERGER BERMAN GROUP LLC.
This table shows 244 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.